Rare diseases
Investigational molecules
Locations
Study on the Long-Term Safety of Relacorilant for Patients with Cushing Syndrome
BulgariaStudy on UGN-102 (Mitomycin) for Treating Low Grade Non-Muscle Invasive Bladder Cancer in Patients at Intermediate Risk of Recurrence
BulgariaStudy of tozorakimab effectiveness and safety in former smokers with Chronic Obstructive Pulmonary Disease (COPD) who experience disease flare-ups
BulgariaStudy on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis
BulgariaStudy of single-dose oritavancin safety and tolerability in children with acute bacterial skin and skin structure infections
BulgariaStudy of NNC0519-0130 and semaglutide in people with chronic kidney disease who are overweight or obese, with or without type 2 diabetes
BulgariaStudy on the Effects of Zasocitinib for Patients with Moderate to Severe Ulcerative Colitis
BulgariaStudy of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment
BulgariaStudy of Debio 4228 for Patients with Advanced or Metastatic Prostate Cancer
BulgariaStudy on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis
BulgariaStudy of secukinumab and prednisone combination therapy for patients with giant cell arteritis (GCA): Evaluation of treatment effectiveness and safety
BulgariaStudy on Acalabrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients Without del(17p) or TP53 Mutation
BulgariaTell us about your condition – we search every trial in Europe and connect you with the right site.
